The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPersonal Assets Trust Regulatory News (PNL)

Share Price Information for Personal Assets Trust (PNL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 483.50
Bid: 482.00
Ask: 483.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.207%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 483.50
PNL Live PriceLast checked at -
Personal Assets is an Investment Trust

To protect and increase shareholders' funds over the long-term by investing in equities, fixed income securities, cash and cash equivalents (which may include gold).

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Half-year Report

5 Dec 2023 07:00

RNS Number : 6422V
Personal Assets Trust PLC
05 December 2023
 

To: RNS

From: Personal Assets Trust plc

LEI: 213800Z7ABM7RLQ41516

Date: 5 December 2023

 

 

INTERIM REPORT FOR THE SIX MONTHS ENDED 31 OCTOBER 2023 (UNAUDITED)

 

FINANCIAL SUMMARY

 

?

Personal Assets Trust ('PAT' or the 'Company') is an investment trust run expressly for private investors.

?

The Company's investment policy is to protect and increase (in that order) the value of shareholders' funds per share over the long term.

?

Over the six months to 31 October 2023 the Company's net asset value per share ('NAV') fell by 2.7% to 468.10 pence on a capital-only return basis. PAT's share price fell by 18.00 pence to 463.00 pence over the same period, being a discount of 1.1% to the Company's NAV at that date.

?

During the period, the Company continued to be positioned very defensively as follows:

 

 

% as at

31 October

2023

% as at

30 April

2023

 

Equities

 

24.8

24.0

 

US TIPS*

 

36.4

33.9

 

US Treasuries (short dated)

 

11.7

14.8

 

UK Gilts (short dated)

 

10.4

13.6

 

UK Index-linked Bonds

 

3.2

-

 

Gold Bullion

 

10.8

9.5

 

Property

 

0.1

0.1

 

UK cash

 

3.2

2.6

 

Overseas cash

 

0.0

0.0

 

Net current (liabilities)/assets

 

(0.6)

1.5

 

 

Total

 

100.0

100.0

 

* Weighted average duration of approximately 5.3 years.

?

Over the six months PAT's shares continued to trade close to NAV under the Company's discount and premium control policy. The Company bought back 24.3 million Ordinary shares (at a cost of £113.5 million) at a small discount. These Ordinary shares are held in treasury.

 

?

Dividends are paid in July, October, January and April of each year. The first interim dividend of 1.4 pence per Ordinary share, was paid to shareholders on 28 July 2023(1) and the second interim dividend of 1.4 pence was paid on 6 October 2023. A third interim dividend of 1.4 pence per Ordinary share will be paid to shareholders on 24 January 2024 and it is the Board's intention, barring unforeseen circumstances, that a fourth interim dividend of 1.4 pence per Ordinary share will be paid in April 2024, making a total for the year of 5.6 pence per Ordinary share.

 

Key Features

 

 

 

As at

31 October

2023

As at

30 April

2023

 

Market Capitalisation

 

£1,700.6m

£1,883.5m

Shareholders' Funds

 

£1,719.3m

£1,884.4m

Shares Outstanding

 

367,295,429

391,570,200

Share Price

 

463.00p

481.00p

NAV per Share

 

468.10p

481.23p

FTSE All-Share Index

 

3,954.35

4,283.83

Discount to NAV

 

(1.1)%

(0.0)%

Earnings per Share

 

4.74p(2)

9.48p(3)

Dividend per Share

 

2.80p(2)

7.70p(1)(3)

 

 

 

(1) A special dividend of 2.1 pence per Ordinary share was also paid in July 2023 in relation to the year ended 30 April 2023. Further details on the dividends paid for the year ended 30 April 2023 are set out in Note 3 below.

(2) For the six month period to 31 October 2023.

(3) Full year.

 

 

Investment Manager's Report

 

Over the half year to 31 October 2023, the net asset value per share ('NAV') of the Company fell by -1.7% while the FTSE All-Share Index ('FTSE') fell by -5.9%. These returns include reinvested dividends. The capital-only returns were -2.7% and -7.7% respectively.

The largest contributors to positive returns were gold and a weakening sterling against the US dollar, adding +0.4% and +0.9% to returns respectively in the period. Equities were the largest detractor, with consumer staples costing -1.5%, on the back of higher yields and concerns around the potential impact from weight-loss drugs on future consumption.

A year ago, we noted that we expected the investment environment to remain challenging. After 15 years of record low interest rates, investors had started to experience the painful adjustment to a new regime of higher interest rates and more volatile inflation. Since then, the interest rate environment has become more restrictive with the Bank of England and the Federal Reserve raising rates to over 5% for the first time since 2008 and 2007 respectively. The implications of this transition have been widespread. The traditional safety and defensiveness provided by fixed income has been absent, as yields have followed interest rates up and prices have fallen. For equity investors, valuations rose across stock markets over the past decade as investors became anchored to ever-higher multiples, justified by low interest rates. Today a rising cost of capital has led to the trend reversing as valuations are reappraised. We are gradually shifting back to a world of more conventional valuations across all asset classes. Private equity and property valuations will inevitably take longer to adjust, as they are not marked to market on a daily basis. The reality remains that investors wishing to sell these illiquid assets today are likely to have to accept a price far lower than that which was on offer a couple of years ago. The return offered by cash is a novelty for many, providing a genuine "risk-free rate" for the first time since the global financial crisis.

Your Company remains very defensively positioned, with approximately 25% in equities, while the adjustment described above is ongoing. We suspect it has a year or two to run, although this could be impacted by external factors, including an increasingly fractious geopolitical backdrop denoted by growing tensions around Taiwan, the war in Ukraine, and the tragic situation in the Middle East.

Equity investors should also consider the risk that profits do not continue to grow as steadily as the market currently expects. In the past, central banks raised interest rates slowly and cut quickly. This time interest rates have increased at the fastest rate since Paul Volker's successful attempt to rein in inflation in the late 1970s. From an inflation-reducing perspective, his measures were effective, and he was subsequently hailed for his inflation-fighting credentials. However, his monetary medicine had the painful side-effects of contributing to a deep recession in the early 1980s. While there is much talk of an expected soft landing for the economy today, we suspect the risks of a recession are rising and they are not currently priced into stock markets. Corporate earnings are highly sensitive to tighter monetary conditions. Bank lending standards are already tightening - the National Federation of Independent Business reports US smaller companies have seen their cost of interest more than double from 4% to almost 10% over the past three years. Larger corporates have wisely termed out their debt but face a headwind of rising interest costs in the future as bonds mature. Corporate earnings often weaken 18-24 months after the peak in interest rates. This is only just beginning to play out and we must remain patient.

During the past six months we have in aggregate reduced our equity exposure, selling into the strength of the recent bear market rally. This is with one notable exception; we began a new holding in Heineken. Heineken is a company we have followed for many years. The business had a challenging pandemic as pubs and bars were closed, but re-opening was not much better, with inflation driving costs higher and affecting profit margins. Many of these issues are now behind the company but the shares have meaningfully de-rated as investors have become disillusioned. The less liquid Heineken Holding shares trade on 13x 12-month forward earnings, while their more liquid NV shares are valued at a hardly racy sub-16x multiple. The share price is at the same level as late 2015. We like to buy into good businesses when others are looking the other way, and the purchase of Heineken is a good example of this patient approach.

Back in 2019, we sold all of the Company's holdings in UK index-linked bonds with real yields lower than -2%, meaning that an investor holding to maturity receives a return 2% below inflation. Real yields troughed at below -3% in 2021. As fixed income yields have risen, real yields have followed them up to +1%. We believe that a government-guaranteed return of inflation plus 1% is attractive compared with returns available elsewhere and we have begun to buy some linkers for the portfolio. We have been careful not to take excessive duration risk, bearing in mind the new regime we have entered which has punished investors flirting with material duration.

 

Over the past 18 months the investment trust sector has seen discounts to NAV blow out. Shareholders in the Company have been protected from their shares trading at a material discount, thanks to the discount control mechanism ('DCM'). Having issued shares in 2020-2022, we began to buy back shares earlier in the year to ensure the share price did not trade at a meaningful discount to NAV. Over the six months to 31 October 2023 we acquired 24.3 million shares for a consideration of £113.5 million. The DCM ensures shareholders do not suffer from the double whammy of a falling NAV and a widening discount to NAV. The buybacks were enhancing to shareholders' NAV to the tune of £0.55 million.

The bear market, which began in stock markets at the beginning of 2022, has some way to go. We are positioned accordingly but are prepared to shift more positively as and when we see improved valuations. It is by buying good companies well that we will drive future returns for the Company.

 

Sebastian Lyon, Investment Manager

 

 

 

Portfolio as at 31 October 2023

 

Shareholders' Funds

Valuation

31 October 2023

Security

Country

Equity Sector

%

£'000

 

Equities

Unilever

UK

Food Producer

3.5

60,736

Nestlé

Switzerland

Food Producer

2.8

48,414

Visa

USA

Financial Services

2.7

46,043

Diageo

UK

Beverages

2.3

39,359

Microsoft

USA

Technology

1.9

33,295

Becton Dickinson

USA

Pharmaceuticals

1.9

32,550

Alphabet

USA

Technology

1.7

28,625

Procter & Gamble

USA

Household Products

1.5

25,481

American Express

USA

Financial Services

1.3

23,233

Franco Nevada

Canada

Mining

1.0

17,336

Heineken

Netherlands

Beverages

1.0

17,017

Pernod-Ricard

France

Beverages

0.9

15,755

Agilent Technologies

USA

Healthcare

0.7

12,868

Experian

UK

Industrial

0.6

9,590

Heineken Holding

Netherlands

Beverages

0.5

8,729

Moody's

USA

Financial Services

0.5

8,102

 Total Equities

 

 

24.8

427,133

Other Investments

US TIPS

USA

36.4

626,235

US Treasuries

USA

11.7

201,740

UK Gilts

UK

10.4

179,168

UK Index-linked Bonds

UK

3.2

54,358

Gold Bullion

10.8

185,827

Total Other Investments

72.5

1,247,328

Total Investments

 

97.3

1,674,461

Property

0.1

1,730

UK cash

3.2

55,026

Overseas cash

0.0

219

Net current liabilities

(0.6)

(12,111)

Total Portfolio

 

100.0

1,719,325

 

 

 

Geographic Analysis of Investments and Currency Exposure As At 31 October 2023

 

UK

USA

Canada

France

Switzerland

Netherlands

Total

 

%

%

%

%

%

%

%

Equities

6.4

12.2

1.0

0.9

2.8

1.5

24.8

Index-linked Bonds

3.2

36.4

-

-

-

-

39.6

Gilts

10.4

-

-

-

-

-

10.4

Treasuries

-

11.7

-

-

-

-

11.7

Gold Bullion

-

10.8

-

-

-

-

10.8

Property

0.1

-

-

-

-

-

0.1

Cash

3.2

0.0

-

-

-

-

3.2

Net current liabilities

(0.6)

-

-

-

-

-

(0.6)

Total

22.7

71.1

1.0

0.9

2.8

1.5

100.0

Net currency exposure

58.1

36.7

-

0.9

2.8

1.5

100.0

 

 

 

 

 

Statement of Principal Risks and Uncertainties

The Board believes that the principal risks to shareholders, which it seeks to mitigate through continual review of its investments and through shareholder communication, are events or developments which can affect the general level of share prices and other financial assets, including, for instance, inflation or deflation, economic recessions and movements in interest rates and currencies.

The Board acknowledges that the continuing uncertainties for global economies and financial markets, with higher levels of inflation and volatility in markets and heightened geopolitical tensions, create risks and uncertainties for the Company. The Board continues to work with the Investment Manager, the Company Secretary and its other advisers to manage these risks as far as possible.

The Board has established and maintains, with the assistance of the Company Secretary, a risk matrix which identifies the key risks to the Company. This register is formally reviewed on a regular basis. Emerging risks that could impact the Company are considered and discussed at each Board meeting, or on an ad hoc basis as required, along with any proposed mitigating actions.

The principal risks and uncertainties faced, and the way in which they are managed, are described in more detail under the heading Principal Risks and Risk Management within the Strategic Report in the Company's Annual Report for the year ended 30 April 2023.

The Company's principal risks and uncertainties have not changed since the date of the Annual Report and are not expected to change for the remaining six months of the Company's financial year.

Going Concern

The Directors believe, in the light of the controls and review processes noted above and bearing in mind the nature of the Company's business and assets, which are considered readily realisable if required, that the Company has adequate resources to continue operating for the foreseeable future. For this reason, they continue to adopt the going concern basis in preparing the financial statements.

Related Party Transactions

Details of related party transactions are contained in the Annual Report for the year ended 30 April 2023. There have been no material changes in the nature and type of the related party transactions as stated within the Annual Report.

Directors' Responsibility Statement in Respect of the Interim Report

We confirm that to the best of our knowledge:

· the condensed set of financial statements has been prepared in accordance with IAS 34 'Interim Financial Reporting';

· the Investment Manager's Report include a fair review of the information required by the Disclosure Guidance and Transparency Rules (DTR) 4.2.7R, being an indication of important events that have occurred during the first six months of the financial year and their impact on the condensed set of financial statements;

· the Statement of Principal Risks and Uncertainties shown above is a fair review of the information required by DTR 4.2.7R; and

· the condensed financial statements include a fair review of the information required by DTR 4.2.8R, being related party transactions that have taken place in the first six months of the current financial year and that have materially affected the financial position or performance of the Company during the period, and any changes in the related party transactions described in the last Annual Report that could do so.

 

On behalf of the Board,

Iain Ferguson, Chairman

5 December 2023

 

 

 

For further information, contact:

 

Sebastian Lyon

Investment Manager

Tel: 0207 499 4030

 

Carron Dobson

Juniper Partners Limited, Company Secretary

Tel: 0131 378 0500

 

 

 

 

Condensed Income Statement

For the six months ended 31 October 2023

 

(Unaudited)

Six months ended

31 October 2023

Revenue

Capital

 

return

return

Total

£'000

£'000

£'000

 

 

 

Investment income

24,743

-

24,743

Other operating income

394

-

394

Losses on investments held at fair value through profit or loss

-

(28,214)

(28,214)

Foreign exchange losses

-

(20,040)

(20,040)

 

 

 

Total income

25,137

(48,254)

(23,117)

Expenses

(2,788)

(3,172)

(5,960)

 

 

 

Return before taxation

22,349

(51,426)

(29,077)

Taxation

(4,324)

793

(3,531)

 

 

 

Return for the period

18,025

(50,633)

(32,608)

 

 

 

 

Return per share (pence)

 

4.74

 

(13.31)

(8.57)

 

The 'Return for the Period' is also the 'Total Comprehensive Income for the Period', as defined in IAS1 (revised), and no separate Statement of Comprehensive Income has been presented.

The 'Total' column of this statement represents the Company's Income Statement, prepared in accordance with International Financial Reporting Standards.

The Revenue Return and Capital Return columns are supplementary to this and are prepared under guidance published by the Association of Investment Companies.

All items in the above statement derive from continuing operations.

 

 

 

 

 

 

 

 

 

Condensed Income Statement

For the six months ended 31 October 2022

(Unaudited)

Six months ended

31 October 2022

Revenue

Capital

return

return

Total

£'000

£'000

£'000

Investment income

23,283

-

23,283

Other operating income

218

-

218

Losses on investments held at fair value through profit or loss

-

(29,380)

(29,380)

Foreign exchange losses

-

(52,475)

(52,475)

 

 

 

Total income

23,501

(81,855)

(58,354)

Expenses

(2,610)

(3,330)

(5,940)

 

 

 

Return before taxation

20,891

(85,185)

(64,294)

Taxation

(3,971)

633

(3,338)

 

 

 

Return for the period

16,920

(84,552)

(67,632)

 

 

 

Return per share (pence)

 

4.44

 

(22.19)

(17.75)

 

 

Condensed Income Statement

For the year ended 30 April 2023

 

(Audited)

 

Year ended

 

30 April 2023

 

Revenue

Capital

 

 

return

return

Total

 

£'000

£'000

£'000

 

 

 

Investment income

48,274

-

48,274

 

Other operating income

1,107

-

1,107

 

Losses on investments held at fair value through profit or loss

-

(54,976)

(54,976)

 

Foreign exchange gains

-

9,419

9,419

 

 

 

 

 

 

Total income

49,381

(45,557)

3,824

 

Expenses

(5,304)

(6,660)

(11,964)

 

 

 

 

 

Return before taxation

44,077

(52,217)

(8,140)

 

Taxation

(7,436)

1,290

(6,146)

 

 

 

 

 

Return for the period

36,641

(50,927)

(14,286)

 

 

 

 

 

Return per share (pence)

9.48

(13.18)

(3.70)

 

Condensed Statement of Financial Position

As at 31 October 2023

 

(Unaudited)

(Unaudited)

(Audited)

31 October

31 October

30 April

2023

2022

2023

£'000

£'000

£'000

 

 

Non-current assets

 

 

Investments held at fair value through profit or loss

 

 

1,674,461

 

1,714,919

 

1,805,933

Property

1,730

2,144

1,730

Net current assets

43,134

104,803

76,689

 

 

 

 

Net assets

1,719,325

1,821,866

1,884,352

 

 

 

Total equity

1,719,325

1,821,866

1,884,352

 

 

 

 

Net asset value per Ordinary share (pence)

468.10

470.27

481.23

 

 

 

 

 

 

 

Condensed Statement of Changes in Equity

For the six months ended 31 October 2023

 

 

 

 

 

(Unaudited)

(Unaudited)

(Audited)

 

 

Six months

Six months

Year

ended

ended

ended

31 October

31 October

30 April

2023

2022

2023

£'000

£'000

£'000

 

 

Opening equity shareholders' funds

1,884,352

1,814,360

1,814,360

Return for the period

(32,608)

(67,632)

(14,286)

Ordinary dividends paid

(18,867)

(15,970)

(26,919)

Issue of Ordinary shares

-

95,502

121,384

Buyback of Ordinary shares

(113,552)

(4,394)

(10,187)

 

 

 

Closing equity shareholders' funds

1,719,325

1,821,866

1,884,352

 

 

 

 

 

 

Condensed Cash Flow Statement

For the six months ended 31 October 2023

 

 

 

(Unaudited)

(Unaudited)

(Audited)

 

 

Six months

Six months

Year

ended

ended

ended

31 October

31 October

30 April

2023

2022

2023

£'000

£'000

£'000

Net cash inflow/(outflow) from operating activities

 

 

5,839

 

(2,139)

 

(2,146)

Net cash inflow/(outflow) from investing

 

activities

130,005

(11,841)

(81,532)

 

 

 

Net cash inflow/(outflow) before financing

 

activities

135,844

(13,980)

(83,678)

Net cash (outflow)/inflow from financing

 

activities

(131,028)

78,174

87,324

 

 

 

Net increase in cash and

 

cash equivalents

4,816

64,194

3,646

Cash and cash equivalents at the start of

 

the period

50,014

47,944

47,944

Effect of exchange rate changes

415

(2,090)

(1,576)

 

 

 

Cash and cash equivalents at the end of

 

the period

55,245

110,048

50,014

 

 

 

 

 

 

NOTES

 

1. The condensed financial statements have been prepared in accordance with International Financial Reporting Standard ('IFRS') IAS 34 'Interim Financial Reporting' and the accounting policies set out in the statutory accounts of the Company for the year ended 30 April 2023. The condensed financial statements do not include all of the information required for a complete set of IFRS financial statements and should be read in conjunction with the financial statements of the Company for the year ended 30 April 2023, which were prepared under full IFRS requirements.

2. The return per Ordinary share figure is based on the net loss for the six months of £32,608,000 (six months ended 31 October 2022: net loss of £67,632,000; year ended 30 April 2023: net loss of £14,286,000) and on 380,501,888 (six months ended 31 October 2022: 380,991,218; year ended 30 April 2023: 386,416,856) Ordinary shares, being the weighted average number of Ordinary shares in issue during the respective periods.

3. In respect of the year ending 30 April 2024 the Board has declared a first interim dividend of 1.4 pence per Ordinary share, which was paid on 28 July 2023 and a second interim dividend of 1.4 pence per Ordinary share, which was paid on 6 October 2023. A third interim dividend of 1.4 pence per Ordinary share will be paid to shareholders on 24 January 2024 and it is the Board's intention, barring unforeseen circumstances, that a fourth interim dividend of 1.4 pence per Ordinary share will be paid in April 2024, making a total for the year of 5.6 pence per Ordinary share. In respect of the year ended 30 April 2023 the Board declared four interim dividends equivalent to 1.4 pence per Ordinary share and a special dividend equivalent to 2.1 pence per Ordinary share. This gave a total dividend for the year ended 30 April 2023 of 7.7 pence per Ordinary share.

4. At 31 October 2023 there were 367,295,429 Ordinary shares in issue (31 October 2022: 387,409,400; 30 April 2023: 391,570,200). During the six months ended 31 October 2023 the Company bought back 24,274,771 Ordinary shares.

5. The Board has considered the requirements of IFRS 8 'Operating Segments'. The Board is of the view that the Company is engaged in a single segment of business, being that of investing in equity shares, fixed interest securities and other investments, and that therefore the Company has only a single operating segment.

6. The Company held the following categories of financial instruments as at 31 October 2023:

 

Level 1

£'000

Level 2

£'000

Level 3

£'000

Total

£'000

Investments

1,674,461

-

-

1,674,461

Current liabilities

-

(17,282)

-

(17,282)

Total

1,674,461

(17,282)

-

1,657,179

The above table provides an analysis of investments based on the fair value hierarchy described below and which reflects the reliability and significance of the information used to measure their fair value. The levels are determined by the lowest (that is, the least reliable or least independently observable) level of impact that is significant to the fair value measurement for the individual investment in its entirety as follows:

Level 1 reflects financial instruments quoted in an active market. The Company's investment in Gold Bullion has been included in this level.

Level 2 reflects financial instruments the fair value of which is evidenced by comparison with other observable current market transactions in the same instrument or based on a valuation technique the variables of which include only data from observable markets. The Company's forward currency contract has been included in this level as fair value is achieved using the foreign exchange spot rate and forward points which vary depending on the duration of the contract.

Level 3 reflects financial instruments the fair value of which is determined in whole or in part using a valuation technique based on assumptions that are not supported by prices from observable market transactions in the same instrument and not based on available observable market data.

There were no transfers of investments between levels in the period ended 31 October 2023.

The following table summarises the Company's Level 1 investments that were accounted for at fair value in the period to 31 October 2023.

 

 

£'000

Opening book cost

1,626,845

Opening fair value adjustment

179,088

Opening valuation

1,805,933

Movement in the period:

Purchases at cost

250,570

Effective yield adjustment

11,267

Sales - proceeds

(365,095)

- losses on sales

(527)

Decrease in fair value adjustment

(27,687)

Closing valuation at 31 October 2023

1,674,461

Closing book cost

1,523,060

Closing fair value adjustment

151,401

Closing valuation at 31 October 2023

1,674,461

 

Other aspects of the Company's financial risk management objectives and policies are consistent with those disclosed in the consolidated financial statements as at and for the year ended 30 April 2023.

The fair value of the Company's financial assets and liabilities as at 31 October 2023 was not materially different from their carrying values in the financial statements.

7. These are not full statutory accounts in terms of Section 434 of the Companies Act 2006 and are unaudited. Statutory accounts for the year ended 30 April 2023, which received an unqualified audit report and which did not contain a statement under Section 498 of the Companies Act 2006, have been lodged with the Registrar of Companies. No full statutory accounts in respect of any period after 30 April 2023 have been reported on by the Company's auditors or delivered to the Registrar of Companies.

8. A copy of the Interim Report is available on the Company's website at www.patplc.co.uk. Shareholders are encouraged to visit the website for further information on the Company.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR DDBDDIBGDGXS
Date   Source Headline
3rd May 202412:50 pmRNSHolding(s) in Company
3rd May 202412:32 pmRNSNet Asset Value(s)
2nd May 20245:09 pmRNSTransaction in Own Shares
2nd May 202412:33 pmRNSNet Asset Value(s)
1st May 20245:18 pmRNSTransaction in Own Shares
1st May 202411:53 amRNSNet Asset Value(s)
1st May 202410:42 amRNSTotal Voting Rights
30th Apr 20245:05 pmRNSTransaction in Own Shares
30th Apr 202412:12 pmRNSNet Asset Value(s)
29th Apr 202412:21 pmRNSNet Asset Value(s)
26th Apr 20244:49 pmRNSTransaction in Own Shares
26th Apr 202411:36 amRNSNet Asset Value(s)
25th Apr 202412:43 pmRNSNet Asset Value(s)
24th Apr 20245:00 pmRNSTransaction in Own Shares
24th Apr 202411:43 amRNSNet Asset Value(s)
23rd Apr 20245:04 pmRNSTransaction in Own Shares
23rd Apr 202411:23 amRNSNet Asset Value(s)
22nd Apr 20245:38 pmRNSTransaction in Own Shares
22nd Apr 202412:09 pmRNSNet Asset Value(s)
19th Apr 20245:11 pmRNSTransaction in Own Shares
19th Apr 202412:02 pmRNSNet Asset Value(s)
18th Apr 20244:57 pmRNSTransaction in Own Shares
18th Apr 20243:25 pmRNSDirector/PDMR Shareholding
18th Apr 20243:24 pmRNSDirector/PDMR Shareholding
18th Apr 20243:23 pmRNSDirector/PDMR Shareholding
18th Apr 20243:23 pmRNSDirector/PDMR Shareholding
18th Apr 202411:55 amRNSNet Asset Value(s)
17th Apr 20244:30 pmRNSTransaction in Own Shares
17th Apr 202410:40 amRNSNet Asset Value(s)
16th Apr 202410:55 amRNSNet Asset Value(s)
15th Apr 202412:51 pmRNSNet Asset Value(s)
12th Apr 20244:28 pmRNSTransaction in Own Shares
12th Apr 202411:47 amRNSNet Asset Value(s)
11th Apr 202410:56 amRNSNet Asset Value(s)
10th Apr 20244:19 pmRNSTransaction in Own Shares
10th Apr 20241:01 pmRNSDirectorate Change
10th Apr 202410:40 amRNSNet Asset Value(s)
9th Apr 20245:24 pmRNSTransaction in Own Shares
9th Apr 20241:07 pmRNSNet Asset Value(s)
8th Apr 20244:33 pmRNSTransaction in Own Shares
8th Apr 202411:24 amRNSNet Asset Value(s)
5th Apr 202411:58 amRNSNet Asset Value(s)
4th Apr 20244:38 pmRNSTransaction in Own Shares
4th Apr 202411:58 amRNSNet Asset Value(s)
3rd Apr 20244:36 pmRNSTransaction in Own Shares
3rd Apr 202412:07 pmRNSNet Asset Value(s)
2nd Apr 20244:52 pmRNSTransaction in Own Shares
2nd Apr 202412:23 pmRNSNet Asset Value(s)
2nd Apr 20249:39 amRNSTotal Voting Rights
28th Mar 20244:41 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.